Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

“Liver cancer is common. It causes immense suffering and death, and the saddest part for me as a physician is that most of ...

Men with cirrhosis have a significantly higher risk for liver-related complications ― particularly hepatocellular carcinoma ― ...

One of the newest treatments for fatty liver is an oral medication called resmetirom (Rezdiffra). It was approved by the FDA in March 2024 to treat people in advanced stages of MASLD.

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access ...

Simple lifestyle changes could drastically cut cases of liver cancer, according to academics. The Lancet Commission on liver ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

It is estimated that one in five people in Sweden has MASLD, previously called non-alcoholic fatty liver disease, and globally it may be as many as three out of ten. Common risk factors are ...

Fatty liver disease, often overlooked due to its silent progression, is emerging as a major public health concern with potentially life-threatening consequences. Health experts warn that the condition ...

A recent Lancet study reveals that 60% of liver cancer cases are preventable, urging immediate action against rising obesity, alcohol consumption, and viral hepatitis. With diagnoses exceeding 905,000 ...

In fact, heart disease is the most common cause of death among people who have metabolic dysfunction-associated steatotic liver disease (MASLD) (previously known as non-alcoholic liver disease).

Fatty liver disease, including NAFLD/MASLD, involves fat buildup in the liver. This can progress to NASH/MASH, fibrosis, ...